Drugs Made In America Acquisition II Ord Shs
DMII
查看詳細走勢圖
9.960USD
-0.010-0.10%
收盤 01/23, 16:00（美東）報價延遲15分鐘
653.13M總市值
--本益比TTM
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
-0.10%
5天
0.00%
1月
+0.61%
6月
0.00%
今年開始到現在
+0.61%
1年
0.00%
查看詳細走勢圖
TradingKey 股票評分
由於缺少必要的數據，暫時無法對該公司進行評分
Drugs Made In America Acquisition II Ord Shs新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Drugs Made In America Acquisition II Ord Shs簡介
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
公司代碼DMII
公司Drugs Made In America Acquisition II Ord Shs
CEOStockwell (Lynn)
網址
相關品種
-3.35%
0.00%
-0.12%
-1.32%
-0.98%
-0.46%
0.00%
+1.58%
-0.09%
-0.68%
-0.10%
0.00%
+0.09%
-0.09%
-0.19%
0.00%
-0.67%
0.00%
-0.19%熱門品種
